Skip to main content
. 2012 Jul;22(7):717–724. doi: 10.1089/thy.2011.0380

FIG. 5.

FIG. 5.

Effect of docetaxel and imatinib in FRO tumor xenograft model. FRO cells were implanted and imatinib was injected i.p. at a dose of 50 mg/kg/day for 14 days, beginning on day 9 after tumor implantation. Docetaxel was injected i.p. at a dose of 5 mg/kg on days 9 and 16. Combined treatment mice were given both drugs. Control group mice received vehicle injection only. Each point represents mean±SD of 10 tumors (in five mice). *p<0.01 versus any other group. i.p., intraperitoneally.